Cresco Labs Inc.
CRLBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.07 | 0.10 | 0.06 | -0.04 |
| FCF Yield | 34.53% | 0.16% | -12.56% | -4.72% |
| EV / EBITDA | 7.52 | -69.76 | -106.19 | -13.70 |
| Quality | ||||
| ROIC | 47.59% | -9.12% | -10.84% | -16.40% |
| Gross Margin | 50.32% | 42.79% | 48.30% | 49.45% |
| Cash Conversion Ratio | -2.19 | -0.33 | -0.09 | -0.05 |
| Growth | ||||
| Revenue 3-Year CAGR | -4.92% | -2.10% | 20.95% | 85.59% |
| Free Cash Flow Growth | 15,616.76% | 101.03% | 18.38% | 9.48% |
| Safety | ||||
| Net Debt / EBITDA | 4.62 | -39.63 | -53.79 | -2.55 |
| Interest Coverage | 1.82 | -1.36 | -1.44 | -4.17 |
| Efficiency | ||||
| Inventory Turnover | 4.32 | 3.79 | 3.24 | 3.04 |
| Cash Conversion Cycle | 96.61 | 95.84 | 113.90 | 111.57 |